Acorah Software Products - Accounts Production 15.0.500 false true 31 March 2023 1 April 2022 false 1 April 2023 31 March 2024 31 March 2024 10799442 Dr RK Singh Mrs EM Singh iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10799442 2023-03-31 10799442 2024-03-31 10799442 2023-04-01 2024-03-31 10799442 frs-core:CurrentFinancialInstruments 2024-03-31 10799442 frs-core:RevaluationReserve 2023-04-01 2024-03-31 10799442 frs-core:RevaluationReserve 2023-03-31 10799442 frs-core:RevaluationReserve 2024-03-31 10799442 frs-core:ShareCapital 2024-03-31 10799442 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 10799442 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10799442 frs-bus:FilletedAccounts 2023-04-01 2024-03-31 10799442 frs-bus:SmallEntities 2023-04-01 2024-03-31 10799442 frs-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 10799442 frs-bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 10799442 frs-core:UnlistedNon-exchangeTraded 2024-03-31 10799442 frs-core:UnlistedNon-exchangeTraded 2023-03-31 10799442 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-03-31 10799442 frs-core:AdditionsToInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 10799442 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 10799442 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-03-31 10799442 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-03-31 10799442 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 10799442 frs-bus:Director1 2023-04-01 2024-03-31 10799442 frs-bus:Director2 2023-04-01 2024-03-31 10799442 frs-countries:EnglandWales 2023-04-01 2024-03-31 10799442 2022-03-31 10799442 2023-03-31 10799442 2022-04-01 2023-03-31 10799442 frs-core:CurrentFinancialInstruments 2023-03-31 10799442 frs-core:RevaluationReserve 2023-03-31 10799442 frs-core:ShareCapital 2023-03-31 10799442 frs-core:RetainedEarningsAccumulatedLosses 2023-03-31
Registered number: 10799442
Torwood Medical Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 10799442
2024 2023
Notes £ £ £ £
FIXED ASSETS
Investments 4 166,791 144,199
166,791 144,199
CURRENT ASSETS
Debtors 5 72,065 48,949
Cash at bank and in hand 63,329 29,972
135,394 78,921
Creditors: Amounts Falling Due Within One Year 6 (40,676 ) (39,296 )
NET CURRENT ASSETS (LIABILITIES) 94,718 39,625
TOTAL ASSETS LESS CURRENT LIABILITIES 261,509 183,824
NET ASSETS 261,509 183,824
CAPITAL AND RESERVES
Called up share capital 7 100 100
Revaluation reserve 8 16,146 (6,281 )
Profit and Loss Account 245,263 190,005
SHAREHOLDERS' FUNDS 261,509 183,824
Page 1
Page 2
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr RK Singh
Director
23/07/2024
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Torwood Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10799442 . The registered office is 36 Endcliffe Grove Avenue, Sheffield, S10 3EJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

2.3. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.


3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
4. Investments
Unlisted
£
Cost
As at 1 April 2023 144,199
Additions 165
Revaluations 22,427
As at 31 March 2024 166,791
Provision
As at 1 April 2023 -
As at 31 March 2024 -
Net Book Value
As at 31 March 2024 166,791
As at 1 April 2023 144,199
5. Debtors
2024 2023
£ £
Due within one year
Trade debtors 72,065 48,949
Page 3
Page 4
6. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Corporation tax 15,080 14,290
Accruals and deferred income 7,286 7,452
Directors' loan accounts 18,310 17,554
40,676 39,296
7. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 100 100
8. Reserves
Revaluation Reserve
£
As at 1 April 2023 (6,281 )
Transfer to profit and loss 22,427
As at 31 March 2024 16,146
Page 4